Neutralizing antibodies against SARS-CoV-2 are higher but decline faster in mRNA vaccinees compared to individuals with natural infection

<h3>Background</h3><p dir="ltr">Waning protection against emerging SARS-CoV-2 variants by pre-existing antibodies elicited because of current vaccination or natural infection is a global concern. Whether this is due to the waning of immunity to SARS-COV-2 remains unclear....

Full description

Saved in:

Bibliographic Details
Main Author:	Haissam Abou-Saleh (497840) (author)
Other Authors:	Bushra Y Abo-Halawa (14619731) (author), Salama Younes (14619758) (author), Nadin Younes (4863280) (author), Duaa W. Al-Sadeq (10976754) (author), Farah M Shurrab (14619787) (author), Na Liu (102929) (author), Hamda Qotba (12794976) (author), Nader Al-Dewik (4166527) (author), Ahmed Ismail (2671822) (author), Hadi M Yassine (85827) (author), Laith J Abu-Raddad (11868161) (author), Gheyath K Nasrallah (14723289) (author)
Published:	2022
Subjects:	Biomedical and clinical sciences Medical microbiology Pharmacology and pharmaceutical sciences mRNA vaccines waning neutralizing antibody Anti-S1-IgA SRBD-IgM
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Neutralizing antibodies against SARS-CoV-2 are higher but decline faster in mRNA vaccinees compared to individuals with natural infection

Similar Items